Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
home / between-the-lines / trifluridine-tipiracil-and-bevacizumab-in-refractory-metastatic-colorectal-cancer
Marwan G. Fakih, MD, and Atif Hussein, MD, MMM, FACP, review data from the SUNLIGHT study and discuss their impact on the overall treatment landscape in metastatic colorectal cancer.